Zepatier Approved for Chronic Hepatitis C
Zepatier, a fixed-dose two drug combination, has been approved for the treatment of Hepatitis C
Zepatier (a combination of elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with the hepatitis C virus, genotypes 1 and 4.
What Drives Me? Getting to an AIDS-Free Generation
Douglas M. Brooks, MSW, Director of the Office of National AIDS Policy
Recently, I had the chance to sit down with my good friend and colleague, Jamal Brown, Press Secretary for the White House Office of Management and Budget, to talk about priorities for achieving the goals of the National HIV/AIDS Strategy through 2016 and my personal connection to HIV/AIDS work. Check out our chat here:
Read more: What Drives Me? Getting to an AIDS-Free Generation
In This Issue
We're happy to launch the 2016 Black AIDS Weekly in connection with Black History Month and to kick off National Black HIV/AIDS Awareness Day. During our hiatus we have been very busy, including designing a new masthead for the Black AIDS Weekly and starting a redesign on BlackAIDS.org. We look forward to finding out what you think of the new masthead and will keep you informed as the work on the website unfolds.
New Approach Might Boost HIV Testing Rates
Patient doesn't opt out and takes HIV test
Telling people they'll be screened for HIV unless they decline to be tested -- an approach known as "opt-out" testing -- could significantly increase the number of patients who agree to be tested, new research suggests.
States Simplify Medicaid Sign-Ups
Patient navigator demonstrates simplified sign-up process
Getting on Medicaid has never been so easy.
In the past two years, 31 states and the District of Columbia have expanded eligibility for Medicaid under the Affordable Care Act, but even more have simplified sign-ups and renewals, according to a 50-state survey released Thursday.